AAAAAA
Results:
1-18
|
Results: 18
Authors:
ANDERSSON F
KARTMAN B
ANDERSSON OK
Citation: F. Andersson et al., COST-EFFECTIVENESS OF FELODIPINE-METOPROLOL (LOGIMAX(R)) AND ENALAPRIL IN THE TREATMENT OF HYPERTENSION, Clinical and experimental hypertension, 20(8), 1998, pp. 833-846
Authors:
ANDERSSON OK
ALMGREN T
PERSSON B
SAMUELSSON O
HEDNER T
WILHELMSEN L
Citation: Ok. Andersson et al., SURVIVAL IN TREATED HYPERTENSION - FOLLOW-UP-STUDY AFTER 2 DECADES, BMJ. British medical journal, 317(7152), 1998, pp. 167-171
Authors:
ANDERSSON OK
NELDAM S
Citation: Ok. Andersson et S. Neldam, CANDESARTAN CILEXETIL VS LOSARTAN, Journal of human hypertension, 12(6), 1998, pp. 419-420
Authors:
ANDERSSON OK
Citation: Ok. Andersson, TOLERABILITY OF A MODERN ANTIHYPERTENSIVE AGENT - CANDESARTAN CILEXETIL, Basic research in cardiology, 93, 1998, pp. 54-58
Authors:
SIEWERTDELLE A
LJUNGMAN S
ANDERSSON OK
WILHELMSEN L
Citation: A. Siewertdelle et al., DOES TREATED PRIMARY HYPERTENSION CAUSE END-STAGE RENAL-DISEASE - A 20-YEAR FOLLOW-UP OF THE PRIMARY PREVENTION STUDY IN GOTEBORG, SWEDEN, Journal of hypertension, 16, 1998, pp. 16-16
Authors:
HOLMANG A
MULLER M
ANDERSSON OK
LONNROTH P
Citation: A. Holmang et al., MINIMAL INFLUENCE OF BLOOD-FLOW ON INTERSTITIAL GLUCOSE AND LACTATE-NORMAL AND INSULIN-RESISTANT MUSCLE, American journal of physiology: endocrinology and metabolism, 37(3), 1998, pp. 446-452
Authors:
FRIDMAN K
ANDERSSON OK
WYSOCKI M
FRIBERG P
SUNZEL M
Citation: K. Fridman et al., ACUTE EFFECTS OF CANDESARTAN CILEXETIL (THE NEW ANGIOTENSIN-II ANTAGONIST) ON SYSTEMIC AND RENAL HEMODYNAMICS IN HYPERTENSIVE PATIENTS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 497-501
Authors:
WYSOCKI M
ANDERSSON OK
PERSSON B
BAGGE U
Citation: M. Wysocki et al., VASOCONSTRICTION DURING ACUTE HYPERVOLEMIC HEMODILUTION IN HYPERTENSIVE PATIENTS IS NOT PREVENTED BY CALCIUM BLOCKADE, Angiology, 49(1), 1998, pp. 41-48
Authors:
FRIDMAN K
ANDERSSON OK
WYSOCKI M
FRIBERG P
Citation: K. Fridman et al., EFFECTS OF AN ACUTE DOSE OF 16 MG CANDESARTAN CILEXETIL ON SYSTEMIC AND RENAL HEMODYNAMICS IN HYPERTENSIVE PATIENTS, Journal of human hypertension, 11, 1997, pp. 43-44
Authors:
ANDERSSON OK
NELDAM S
Citation: Ok. Andersson et S. Neldam, A COMPARISON OF THE ANTIHYPERTENSIVE EFFECTS OF CANDESARTAN CILEXETILAND LOSARTAN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 11, 1997, pp. 63-64
Authors:
MULLER M
HOLMANG A
ANDERSSON OK
EICHLER HG
LONNROTH P
Citation: M. Muller et al., MEASUREMENT OF INTERSTITIAL MUSCLE GLUCOSE AND LACTATE CONCENTRATIONSDURING AN ORAL GLUCOSE-TOLERANCE TEST, American journal of physiology: endocrinology and metabolism, 34(6), 1996, pp. 1003-1007
Authors:
JANSSON PAE
GUDBJORNSDOTTIR HS
ANDERSSON OK
LONNROTH PN
Citation: Pae. Jansson et al., THE EFFECT OF METFORMIN ON ADIPOSE-TISSUE METABOLISM AND PERIPHERAL-BLOOD FLOW IN SUBJECTS WITH NIDDM, Diabetes care, 19(2), 1996, pp. 160-164
Authors:
WYSOCKI M
ANDERSSON OK
PERSSON B
BAGGE U
BRAIDE M
Citation: M. Wysocki et al., HEMORHEOLOGIC EFFECTS OF VASODILATION IN ESSENTIAL-HYPERTENSION, Angiology, 47(9), 1996, pp. 869-878
Authors:
DAHLOF B
ANDERSSON OK
Citation: B. Dahlof et Ok. Andersson, A FELODIPINE-METOPROLOL EXTENDED-RELEASE TABLET - ITS PROPERTIES AND CLINICAL DEVELOPMENT, Journal of human hypertension, 9, 1995, pp. 43-47
Authors:
AGEWALL S
WIKSTRAND J
SAMUELSSON O
PERSSON B
ANDERSSON OK
FAGERBERG B
Citation: S. Agewall et al., THE EFFICACY OF MULTIPLE RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN DURING LONG-TERM FOLLOW-UP, Journal of internal medicine, 236(6), 1994, pp. 651-659
Authors:
SAMUELSSON O
HEDNER T
BERGLUND G
PERSSON B
ANDERSSON OK
WILHELMSEN L
Citation: O. Samuelsson et al., DIABETES-MELLITUS IN TREATED HYPERTENSION - INCIDENCE, PREDICTIVE FACTORS AND THE IMPACT OF NONSELECTIVE BETA-BLOCKERS AND THIAZIDE DIURETICS DURING 15 YEARS TREATMENT OF MIDDLE-AGED HYPERTENSIVE MEN IN THE PRIMARY PREVENTION TRIAL GOTEBORG, SWEDEN, Journal of human hypertension, 8(4), 1994, pp. 257-263
Authors:
AGEWALL S
FAGERBERG B
SAMUELSSON O
PERSSON B
HEDNER T
ANDERSSON OK
WIKSTRAND J
BERGLUND G
Citation: S. Agewall et al., MULTIPLE CARDIOVASCULAR RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN - WHAT CAN BE ACHIEVED, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 3(3), 1993, pp. 128-135
Authors:
PERSSON B
ANDERSSON OK
WYSOCKI M
HEDNER T
KARLBERG B
Citation: B. Persson et al., CALCIUM ANTAGONISM IN ESSENTIAL-HYPERTENSION - EFFECT ON RENAL HEMODYNAMICS AND MICROALBUMINURIA, Journal of internal medicine, 231(3), 1992, pp. 247-252
Risultati:
1-18
|